Skip to content

Extra Wide Field of View Lens Study

A Prospective Cohort Study Evaluating a Novel Colonoscope With a 230-degree Extra-wide Field of View Optics (EFOV)

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT06483503
Acronym
EFOV
Enrollment
60
Registered
2024-07-03
Start date
2024-08-21
Completion date
2025-03-30
Last updated
2025-01-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Colonic Polyp

Brief summary

The goal of this observation study is to learn about the feasibility of a new colonoscope which provides the physician an extra-wide field of view during a screening colonoscopy. The main question this study aims to answer is can this new type of colonoscope locate polyps during clinical use in patients. Patients will undergo a routine colonoscopy for colorectal cancer or polyp surveillance and have one follow-up phone call up to 2 weeks of the colonoscopy.

Interventions

DEVICEEFOV Colonoscope

Routine colonoscopy using the EFOV lens in the colonoscope.

Sponsors

Pentax Medical
Lead SponsorINDUSTRY

Study design

Observational model
CASE_ONLY
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* Screening for colorectal cancer at the age greater than or equal to 50 years, or evaluation of a positive stool test (i-FOBT) or polyp surveillance. * Signed informed consent.

Exclusion criteria

* ASA classification ≥3. * Age \<18 years. * Known or suspicion of inflammatory bowel disease. * Known polyp(s) for polypectomy. * High risk for colorectal cancer, history of extensive polyposis, patients with known genetic disease. * Prior colorectal surgery. * Vulnerable subjects or subjects unable to follow the procedures of the investigation, e.g., due to language problems. * Unable or unwilling to undergo bowel cleansing for colonoscopy. * Female patients who are pregnant or nursing. * Participation in another clinical trial within 30 days prior to the Screening Visit or during this study.

Design outcomes

Primary

MeasureTime frameDescription
Cecal Intubation RateDay 1The proportion of procedures in which the cecum was reached.

Secondary

MeasureTime frameDescription
Ileum Intubation RateDay 1Success rate of reaching the Ileum.
Therapeutic Intervention Success RateDay 1The ability to collect a biopsy or remove a polyp.
Mean number of polyps per coloscopy and its detection rateDay 1Count of number of polyps seen during colonoscopy
Procedure TimeDay 1Total procedure time and separated into cecal insertion time, time to reach ileum and withdrawal time.
Mean number of sessile serrate lesions and its detection rateDay 14Count of number of adenomas/sessile serrate lesions defined by pathology
Patient Satisfaction SurveyDay 14During a follow-up phone call, the patient will be asked a yes or no question to rate their satisfaction of the procedure.
Mean number of adenomas and its detection rateDay 14Count of number of adenomas/sessile serrate lesions defined by pathology

Countries

Germany

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026